Market Research Logo

China Hospital Industry Report, 2015-2018

China Hospital Industry Report, 2015-2018

Stimulated by the demand, the number of hospitals in China rose from 21,979 in 2011 to 26,479 at the end of May 2015, an increase of 4,500 in total. Among them, public hospitals showed an overall decline whereas private hospitals increased rapidly.

During the period from 2011 to late May2015, the number of private hospitals in China advanced 4,713, with the share up from 38.4% to 49.7%. But in point of revenue, China's private hospitals just accounted for 10%.

In terms of medical service, between January and May 2015, China saw 1.2152 billion hospital visits, up 5.4% from a year earlier. Although the number of public hospitals occupied only 50.3% of total hospitals, yet the public hospital visits represented up to 89.1%, which was mainly due to the fact that private hospitals are small in scale and have relatively poor treatment level and lower public awareness.

At present, more investment has gone to specialized hospitals, which have captured long-term attention from social capital, hence a great market demand. As of the end of 2014, the number of specialized hospitals in China were expected to reach 5,449, making up 21.4% of the total. Among them, mental hospitals, maternity hospitals, orthopaedic hospitals, stomatological hospitals, and ophthalmic hospitals constitute the mainstay. Tumor hospitals generated the most revenue while beauty hospitals, ophthalmic hospitals, and stomatological hospitals produced relatively higher profit margin.

In recent years, the State has introduced a series of favorable policies designed to encourage private capital into the hospital industry, thus setting off a wave of social capital inrush to medical service. Currently, many private companies including Aier Eye Hospital Group, TC Medical, Mayinglong Pharm, Shanghai Fosun Pharmaceutical (Group), Jinling Pharmaceutical Company Limited, and Phoenix Healthcare Group have ventured into the field of medical service. Among them, Aier Eye Hospital Group and Shanghai Fosun Pharmaceutical (Group) achieved good results in business development. In H1 2015, the medical service revenue for the two companies totaled RMB1.175 billion and RMB674.4 million, respectively.

As China's largest ophthalmic medical chain institution, Aier Eye Hospital Group have established more than 100 professional ophthalmic hospitals throughout the country, with over 3 million outpatient visits annually. In the past two years, the company set up four industrial merger & acquisition funds used to invest in grand health industry, in the hope of increasing hospital outlets and achieving industrial expansion.

Fosun Pharma specializes in drug manufacturing and research and development meanwhile operating medical service business. In recent years, through self-building, mergers and acquisitions, joint venturing, and affiliation, the company has made continuous expansion in medical service and seen explosive growth in revenue from this field. In 2011-2014, the company’s medical service revenue registered a CAGR of 371.5%. In 2014, the company participated in the privatization of Chindex International, Inc. (“Chindex”), and upon the completion of the privatization transaction, Fosun Industrial held a 42.927% equity interest and at the same time owned “United Family Hospital”, a high-end brand for healthcare services under Chindex.

The report highlights the followings:
Overview of China hospital industry, including number of hospitals, revenue, medical service, competition pattern, summary and forecast, etc.;
Status quo of specialized hospitals in China, including overall operation, development of specialized hospitals of all sorts, etc.;
Development prediction of China hospital industry, including the impact of medical insurance system and urbanization on hospital industry, etc.;
Investment in China hospital industry, including related policies, comparison of public and private hospitals, investment opportunities of social capital, and development model of foreign-funded hospitals, etc.;
Operation, and medical service business of 16 enterprises venturing into hospital industry.

Please Note: PDF E-mail from Publisher purchase option allows up to 10 users and does not allow printing or editing. This functionality will require a Global Site License.

1. Overview of China Hospital Industry
1.1 Definition
1.2 Classification
1.3 Industry Chain
2. Development of China Hospital Industry
2.1 Overview
2.1.1 Number of Hospitals
2.1.2 Distribution
2.2 Revenue
2.2.1 Total Revenue
2.2.2 General Hospitals
2.3 Medical Service
2.4 Competition Pattern
2.5 Summary and Forecast
3. Development of Specialized Hospitals in China
3.1 Overview
3.1.1 Number of Hospitals
3.1.2 Revenue
3.2 Status Quo of Specialized Hospitals of All Kinds
3.2.1 Ophthalmic Hospital
3.2.2 Stomatological Hospital
3.2.3 Orthopedics & Beauty Hospital
3.2.4 Maternity Hospital Obstetrics and Gynecology Hospital
3.2.5 Children’s Hospital
3.2.6 Tumor Hospital
4. Development Forecast of China Hospital Industry
4.1 Status Quo of China Medical Insurance
4.1.1 Medical Insurance System
4.1.2 Medical Insurance Close to Saturation
4.1.3 Medical Insurance for Serious Illness of Urban and Rural Residents
4.2 Urbanization Bolsters Development of the Hospital Industry
4.2.1 Status Quo of Urbanization in China
4.2.2 Urbanization Expects to Optimize Medical Insurance System
4.2.3 Trans-regional Medical Insurance Settlement is to be advanced
4.2.4 Urbanization Incrementation Depends on the Contribution of Medical Insurance System
4.2.5 Medical Insurance Fund Balance Rate Will See Further Decrease
4.2.6 Medical Resource Supply of County-Level Hospitals Will Improve
4.2.7 Urbanization Will Encourage Central Government to Invest in Urban Medical Resources
5. Investment in China Hospital Industry
5.1 Impetus Given by Policies
5.2 Comparison of Public and Private Hospitals
5.2.1 Public Hospitals Play a Leading Role
5.2.2 Private Hospitals Run with Efficiency
5.3 Investment Opportunities of Social Capital
5.3.1 Specialized Medical Field
5.3.2 General Public Hospitals
5.4 Development Orientation and Business Model of Foreign Hospitals
5.4.1 Status Quo of Foreign Hospitals in China
5.4.2 Development Direction
5.4.3 Business Practice
6. Major Private Hospitals in China
6.1 Aier Eye Hospital Group
6.1.1 Profile
6.1.2 Operation
6.1.3 Revenue Structure
6.1.4 Gross Margin
6.1.5 R&D and Investment
6.1.6 Medical Service
6.1.7 Prediction and Outlook
6.2 TC Medical
6.2.1 Profile
6.2.2 Operation
6.2.3 Revenue Structure
6.2.4 Gross Margin
6.2.5 Medical Service
6.2.6 Prediction and Outlook
6.3 Mayinglong Pharm
6.3.1 Profile
6.3.2 Operation
6.3.3 Revenue Structure
6.3.4 Gross Margin
6.3.5 R&D and Investment
6.3.6 Medical Service
6.3.7 Prediction and Outlook
6.4 Shanghai Fosun Pharmaceutical (Group)
6.4.1 Profile
6.4.2 Operation
6.4.3 Revenue Structure
6.4.4 Gross Margin
6.4.5 R&D and Investment
6.4.6 Medical Service
6.4.7 Prediction and Outlook
6.5 Jinling Pharmaceutical Company Limited
6.5.1 Profile
6.5.2 Operation
6.5.3 Revenue Structure
6.5.4 Gross Margin
6.5.5 R&D and Investment
6.5.6 Medical Service
6.5.7 Prediction and Outlook
6.6 Shinva Medical
6.6.1 Profile
6.6.2 Operation
6.6.3 Revenue Structure
6.6.4 Gross Margin
6.6.5 R&D and Investment
6.6.6 Medical Service
6.6.7 Prediction and Outlook
6.7 Xi’an International Medical Investment Co., Ltd.
6.7.1 Profile
6.7.2 Operation
6.7.3 Revenue Structure
6.7.4 Medical Service
6.7.5 Prediction and Outlook
6.8 Inner Mongolia Furui Medical Science
6.8.1 Profile
6.8.2 Operation
6.8.3 Revenue Structure
6.8.4 Medical Service
6.8.5 Prediction and Outlook
6.9 Wuhan Jianmin Pharmaceutical Groups Corp.
6.9.1 Profile
6.9.2 Operation
6.9.3 Revenue Structure
6.9.4 Medical Service
6.9.5 Prediction and Outlook
6.10 Concord Medical Services Holdings Limited
6.10.1 Profile
6.10.2 Operation
6.10.3 Medical Service
6.10.4 Prediction and Outlook
6.11 Phoenix Healthcare Group
6.11.1 Profile
6.11.2 Operation
6.11.3 Medical Service
6.11.4 Prediction and Outlook
6.12 Guizhou Yibai Pharmaceutical
6.12.1 Profile
6.12.2 Operation
6.12.3 Medical Service
6.12.4 Prediction and Outlook
6.13 Kangmei Pharmaceutical
6.13.1 Profile
6.13.2 Operation
6.13.3 Medical Service
6.13.4 Prediction and Outlook
6.14 JNMPT
6.14.1 Profile
6.14.2 Operation
6.14.3 Medical Service
6.14.5 Prediction and Outlook
6.15 China Resources Sanjiu Medical & Pharmaceutical Co., Ltd.
6.15.1 Profile
6.15.2 Operation
6.15.3 Medical Service
6.16 Parkway Pantai
6.16.1 Profile
6.16.2 Development in China

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report